Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
133.55
+0.24 (0.18%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.14B in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.11B
Revenue Growth
+5.85%
P/S Ratio
5.39
Revenue / Employee
$378,149
Employees
114,000
Market Cap
232.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ABT News
- 1 day ago - Best Dividend Aristocrats For October 2025 - Seeking Alpha
- 4 days ago - Abbott Hosts Conference Call for Third-Quarter Earnings - PRNewsWire
- 5 days ago - These Dividend Stocks Have Big Yields and Are Beating the Odds - Barrons
- 9 days ago - Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE - Forbes
- 9 days ago - 1 Dividend King To Hold And 2 Worth Buying Now - Seeking Alpha
- 9 days ago - Abbott Declares 407th Consecutive Quarterly Dividend - PRNewsWire
- 4 weeks ago - Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis - PRNewsWire
- 4 weeks ago - Best Dividend Aristocrats For September 2025 - Seeking Alpha